NIH-supported research demonstrates how genetic variations cause eczema
On Aug. 14, 2020, research supported by the National Institutes of Health delineated how two relatively common variations…
Vaccine refusal and measles outbreaks increased in the U.S.
On Aug. 14, 2020, in the U.S., despite high rates of coverage (>90%) at the national level for…
Medigen Vaccines announced positive results of preclinical data for vaccine candidate against COVID-19
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
2 in 5 schools around the world lacked basic handwashing facilities prior to COVID-19 pandemic
On Aug. 13, 2020, data from the WHO/UNICEF Joint Monitoring Programme (JMP) revealed that 43 per cent of…
ADHD risk may be linked to inflammation during pregnancy
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
Celdara Medical announced receipt of NIH funding for pandemic influenza antiviral development
On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR)…
Biotechnology | Disease | HIV | Life Science News | Medicine | Therapeutics | Vaccine
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government had secured 100 million doses of mRNA-1273. The…
Gilead submited New Drug Application to FDA for Veklury (Remdesivir) for treatment of COVID-19
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
FDA approved oral treatment for spinal muscular atrophy
On Aug. 7, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Evrysdi (risdiplam) to treat patients…
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
Altimmune Completed enrollment in phase 1b clinical trial of NasoShield, a single dose intranasal anthrax vaccine candidate
On Aug. 7, 2020, Altimmune announced that it had completed enrollment in its Phase 1b clinical trial of…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Nanotechnology | Pharmaceutical | Vaccine
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
RedHill Biopharma’s phase 2/3 COVID-19 study approved in Mexico
On Aug. 6, 2020, RedHill Biopharma announced approval from the Mexican Federal Committee for the Protection against Sanitary…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Nanotechnology | Therapeutics | Vaccine
Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
First clone of endangered Przewalski’s horse born in conservation effort to save the species
On Aug. 6, 2020, the world’s first successfully cloned endangered Przewalski’s horse was born. Revive & Restore, San…
Rapid diagnostic for gonorrhea won $19 million federal prize competition to combat antibiotic resistance
On Aug. 5, 2020, a diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea…
NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
Tecan’s automation technology leveraged by Thermo Fisher to scale-up COVID-19 testing globally
On Aug. 5, 2020, the Tecan Group and Thermo Fisher Scientific announced a collaboration to enable scaled-up COVID-19…
AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
Mateon and Abiogenesis to initiate clinical study to test Artemisinin as a treatment for COVID-19 in India
On Aug. 4, 2020, Mateon Therapeutics and Abiogenesis announced they had initiated a ARTI-19 randomized, controlled, multi-site India…
Precipio launched Covid-19 antibody test in its CLIA laboratory
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
Novavax announced positive phase 1 data for its COVID-19 vaccine candidate
On Aug. 4, 2020, Novavax announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of…
Cocrystal Pharma announced publication of positive data demonstrating potent in vitro inhibition against Coronavirus
On Aug. 4, 2020, Cocrystal Pharma announced the publication of preclinical animal studies of coronavirus antiviral compounds in…
Oxford University and ZOE partnered on COVID-19 treatment trials
On Aug. 3, 2020, the University of Oxford and the COVID Symptom Study joined forces to widen access…
La Jolla Institute for Immunology received $1 million from GHR Foundation in support of COVID-19 research
On Aug. 3, 2020, the La Jolla Institute for Immunology (LJI) announced a $1 million gift from GHR…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Oncology
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…